Search

BHF-funded researchers have identified new genetic clues in people who’ve had small and ‘silent’ strokes that are difficult to treat and a major cause of vascular dementia.

RESEARCH

Imperial College London | Dr Michael J Mullen

Marfan syndrome is a life-threatening inherited disorder that causes the major blood vessel from the heart – the aorta – to expand, increasing the risk of dissection (where the aorta tears). Drugs called beta blockers slow the expansion ...

Vascular dementia is the second most common type of dementia, affecting around 150,000 people in the UK. There is no cure, but we fund research that could change that.

A stroke survivor is warning others to watch out for unusual symptoms after joining a study we're funding.

TWIST explored whether people who wake up with a stroke should should be treated with clot-busting medicine

Scientists have discovered three new proteins that can be injected directly into the heart immediately after a heart attack, which could preserve heart function and prevent heart failure.

RESEARCH

University of Edinburgh | Dr Peter Henriksen

Dr Peter Henriksen from the University of Edinburgh is leading a clinical trial to find out if commonly used heart failure drugs can protect the heart in women receiving chemotherapy for breast cancer. Breast cancer is common - the lifet...

A drug already used to treat high blood pressure could be re-purposed as the first treatment to tackle a type of vascular dementia caused by damaged and ‘leaky’ small blood vessels in the brain, according to research we've part-funded and published today in the Journal of Clinical Investigation.

Nearly 20,000 people in Scotland will be included in a clinical trial to determine the best clot busting drug treatment for people after they have suffered a heart attack.

People with signs of damage to their heart during middle age are more likely to develop dementia in later life according to a BHF-funded study